March 17, 2022
Oppilotech and Evariste Technologies Announce Partnership to Develop First-in-Class Antibacterial Programme
Oppilotech Ltd has announced a co-development drug discovery partnership with the UK’s Evariste Technologies, which will use machine learning and artificial intelligence to establish a first-in-class antibacterial programme.
